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Recently, we developed a highly pathogenic variant of simian–human immunodeficiency virus, SHIV-4 (containing the tat,
rev, vpu, and env of the HXB2 strain of HIV-1 in a genetic background of SIVmac239), through a series of four bone
marrow-bone marrow passages—first in rhesus monkeys and then in pig-tailed macaques [Joag et al. (1996) J. Virol. 70,
3189–3197]. Inoculation of pig-tailed macaques with this pathogenic virus (SHIVKU-1) causes subtotal elimination of CD4
1 T
cells and fatal opportunistic infections, usually within 6 months. Genetic characterization of SHIVKU-1 showed that it has a
functional vpu gene (the first codon is ATG vs ACG for the vpu of SHIV-4) and several amino acid substitutions in Env and
nef [Stephens et al. (1997) Virology 231, 313–321]. Two pig-tailed macaques, PPc and PQc, were the first to develop a severe
loss of CD41 T cells and the acquired immune deficiency syndrome and were euthanized at 26 and 105 weeks, respectively.
In this report, we analyzed the changes that occurred in the vpu, nef, and env (gp120) genes of the virus used to inoculate
macaques PPc and PQc and established the chronology of changes that occurred in these viral genes as these two animals
lost their CD41 T cells and progressed to develop acquired immune deficiency syndrome. Compared with SHIV-4, the virus
used to inoculate macaques PPc and PQc had 0, 3, and 0 consensus amino acid changes in the Vpu, gp120, and Nef,
respectively. An analysis of the viral sequences amplified from peripheral blood mononuclear cells samples taken at various
times after inoculation of PPc revealed that the vpu had not reverted to an open reading frame (closed vpu, ACG) at 4 weeks
after inoculation, but by 16 weeks vpu had reverted to an open reading frame (open vpu, ATG). Macaque PQc, which had a
longer course of disease, had a closed vpu at 4 and 16 weeks, but by 28 weeks, both closed and open vpu were detected.
From 39 to 105 weeks, only an open vpu was detected. In both macaques, the reversion to an open vpu correlated well with
the second phase (major) of CD41 T cell loss. An analysis of the nef and env sequences isolated from the same times after
inoculation revealed an association between the reversion of vpu to an open reading frame and the accumulation of
increased numbers of consensus changes in these two viral proteins. These data suggest that the concomitant reversion of
vpu to an open reading frame along with increased substitutions in Nef and gp120 were important genetic changes in the viral
genome that were responsible for the increased and highly efficient rate of replication of the virus in CD41 T cells and
macrophages, which in turn led to elimination of the CD41 T cells and profound loss of immunocompetence in the infected
animals. © 1998 Academic Press
INTRODUCTION
Simian immunodeficiency virus infection of macaques
(SIVmac) has proved to be a useful animal model system
with which to understand the mechanisms by which
human immunodeficiency virus type 1 (HIV-1) causes
disease in humans (Kestler et al., 1990; Ketvin and King,
1990; Desrosiers, 1990, 1995). However, there are major
genetic differences between SIVmac and HIV-1 (Chak-
rabarti et al., 1987; Myers et al., 1992; Joag et al.,
1996b), especially in the env genes. Furthermore, the
clinical syndromes seen in SIVmac infections of ma-
caques and HIV-1 infections of humans are not iden-
tical (Levy, 1993; Schnittman and Fauci, 1994; Pantaleo
and Fauci, 1995). One such difference is that in con-
trast to HIV-infected persons, SIVmac-infected ma-
caques do not lose CD41 T cells before the develop-
ment of acquired immune deficiency syndrome
(AIDS), as observed typically in HIV-1-infected people
(R. Raghavan, et al., unpublished data). In addition, the
role of the HIV-1-specific vpu gene in the pathogenesis
of HIV-1 infection in humans cannot be evaluated in
the SIVmac/macaque model because the gene is not
present in the SIVmac genome (Regier et al., 1990).
Chimeric simian–human immunodeficiency viruses
(SHIVs), constructed with the tat, rev, vpu, and env of
HIV-1 (strain HXB2) within the genetic background of the
pathogenic molecular clone SIVmac239, represent a non-
human primate animal model for analyzing the role of
HIV-1-specific vpu and env genes in the pathogenesis of
the infection caused by this virus. While the initial SHIV
constructed (i.e., SHIV-4) was able to infect and cause
persistent infection in macaques, no loss of CD41 T cells
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occurred, and the infected animals never developed dis-
ease (Li et al., 1992). We confirmed this, but in a series of
sequential passages of SHIV-4, first through rhesus ma-
caques and then through pig-tailed macaques, we de-
rived a pathogenic SHIV (Joag et al., 1996a). The first
pig-tailed macaques to develop disease, PPc and PQc,
were third-passage animals that both developed a bi-
phasic loss of CD41 T cells and were euthanized in a
moribund condition (Joag et al., 1996a; Stephens et al.,
1996). Subsequent passage of the virus in another pig-
tailed macaque yielded SHIVKU-1, a cell-free virus stock
that is capable of causing near-total loss of CD41 T cells
within 4 weeks and AIDS in 70% of the animals within 6
months (Joag et al., 1997). In this report, we analyzed the
sequence changes that occurred in the vpu, nef, and env
genes of the SHIV in macaques PPc and PQc during their
course of infection. Our results indicate an association
between the reversion of the vpu to an open reading
frame and the selection of virus variants that caused the
second (major) phase of CD41 T cell loss and AIDS.
These results suggest that in addition to changes in nef
and env, an open vpu may be required for the pathoge-
nicity of SHIV in macaques.
RESULTS
Correlation between the second phase of CD41 T cell
loss and reversion of vpu to an open reading frame
In an earlier study, we reported that macaques PPc
and PQc had developed a clinical course of disease that
was characterized by a biphasic loss of CD41 T cells.
The first phase of CD41 T cell loss in macaque PPc
occurred within the first 2 weeks after inoculation and
resulted in a decline in the CD41 T cells to ;100 cells/ml
(Fig. 1A). The cell count rebounded to ;800 cells/ml by
12 weeks postinoculation. This was followed by the sec-
ond phase of cell loss, which began at 12–16 weeks
postinoculation and progressed until the death of the
animal, when the count bottomed out at 28 CD41 T
cells/ml (Fig. 1A). The initial decline in the circulating
CD41 T cell count in macaque PQc was ;200–250
cells/ml during the first phase (Fig. 1B). Similar to ma-
caque PPc, the circulating CD41 T cells rebounded such
that by 39 weeks, ;1200 circulating CD41 T cells/ml of
blood were detected. The second phase of CD41 T cell
loss began at 39–42 weeks postinoculation; by 76 weeks,
only 2 CD41 T cells/ml were detected in the blood (Fig.
1B). This loss of CD41 T cells persisted until death of the
animal at 105 weeks. Thus, macaque PPc developed a
short course of disease (;6 months), whereas macaque
PQc developed a more protracted course (; 2 years).
The first codon of the vpu in the original SHIV-4 used to
passage in macaques was ACG instead of ATG (Li et al,
1992). This resulted in failure of the virus to code for a
Vpu protein. Thus, SHIV-4 is considered to have a closed
reading frame. We analyzed the status of the vpu gene
(open, ATG; or closed, ACG) in relationship with the
CD41 T cell counts and cells producing infectious virus
in peripheral blood mononuclear cells (PBMCs) in se-
quentially collected blood samples from both animals
during the course of their infection. For macaque PPc,
the vpu genes isolated from the PBMCs were closed at
4 weeks (before the second wave of CD41 T cell loss),
but at 16 weeks and necropsy (26 weeks), 100% of the
vpu clones isolated had reverted in to an open reading
frame (Fig. 1A). By 18 weeks, macaque PPc had started
a second phase of CD41 T cell decline, and this was
associated with increased numbers of cells in the PB-
MCs, producing infectious virus (Fig. 1A). Examination of
the vpu gene isolated from the spleen, thymus, and
lymph node tissue DNA samples obtained at necropsy
FIG. 1. Correlation among the levels of CD41 T cells (), cells
producing infectious virus ICA (E), and the status of the vpu gene
(closed, 2; open, 1) in macaques PPc (A) and PQc (B). The frequency
of cells producing virus was measured by inoculation of serial dilutions
of PBMCs into indicator cells and examination of cultures for the
presence of CPE as described in the text. CD41 T cell frequencies
were assessed by FACS analysis. The status of the vpu gene was
assessed by PCR amplification followed by sequencing of cloned
genes.
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also revealed that the vpu had opened up in 100% of the
clones (data not shown). In macaque PQc, the vpu genes
isolated from the PBMCs were closed at 4 and 16 weeks,
but by 28 weeks, 50% of the vpu clones isolated from the
PBMCs had reverted to an open reading frame. Analysis
of the vpu isolated from the PBMCs at 39, 57, and 105
weeks postinoculation revealed that 100% of the vpu
clones had reverted to an open reading frame. As shown
in Figure 1B, when 100% of the vpu clones isolated from
macaque PQc were open (39 weeks), there was a gen-
eral increase in the number of cells producing infectious
virus. This was followed soon by the second phase of
CD41 T cell loss. These results indicate that for both PPc
and PQc, there was a reversion of vpu to an open
reading frame in the PBMCs just before or during the
second phase of CD41 T cell loss.
Reversion of the vpu to an open reading frame
correlates with increased consensus amino acid
changes in the Nef and gp120
We determined the number of consensus amino acid
changes in the Nef and gp120 proteins during the course of
infection of macaques PPc and PQc. Analysis of the virus
stock (PRc/PLc bone marrow) used to inoculate macaques
PPc and PQc revealed no consensus amino acid changes
in Nef. In the nef clones isolated from the PBMCs from
macaque PPc at 4 weeks, the predicted Nef had one con-
sensus amino acid substitution (Fig. 2, Table 1). The num-
ber of consensus changes in Nef increased to five at 16
weeks and remained at five changes at necropsy. In the
clones isolated from macaque PQc, no consensus amino
acid changes were found in the Nef at 4, 16, or 28 weeks
(Fig. 3, Table 1). However, at those time periods when only
open vpu clones were detected (39, 57, and 105 weeks), the
number of consensus amino acid substitutions in the Nef
gradually increased from 8 changes at week 29 to 11
changes by week 105 (Fig. 3). Thus, the emergence of viral
variants with increased numbers of consensus amino acid
FIG. 2. Correlation among the level of CD41 T cells (), status of the
vpu gene (closed, 2; open, 1), and the number of predicted consensus
amino acid substitutions in the gp120 (f) and nef (r) genes isolated
from macaque PPc.
TABLE 1
Consensus Amino Acid Substitutions in Nef during the Course of Infection of Macaques PPc and PQc
PLc/PRc BMa PPc PBMCsa PQc PBMCsa
(0)c 4b (1) 16 (5) 26 (5) 4, 16, 28 (0) 39 (8) 57 (7) 105 (11)
None None
A23V R30K R30K R30K
V35G
D37N D37N
S52P
K59R
N72D N72D
K75G
R77K R77K
D96N D96N D96N
T110A T110A T110A
Y133F Y133F
R140G R140G R140G
I144M I144M I144T I144T I144T
E150K E150K
E185L
E188K
E191K E191K E191K
a DNA was extracted from bone marrow (BM) or peripheral blood mononuclear cells (PBMCs), and the nef gene was amplified using appropriate
oligonucleotide primers.
b Weeks postinoculation that samples were collected.
c Number of consensus amino acid substitutions obtained from analysis of five clones from each time period.
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substitutions in Nef occurred more rapidly in macaque PPc
than in macaque PQc.
An analysis of the number of consensus amino acid
substitutions in the gp120 isolated from PPc and PQc is
presented in Table 2. Virus in the bone marrow used to
inoculate macaques PPc and PQc had three consensus
amino acid substitutions in gp120 compared with the
SHIV-4 sequence (Fig. 2, Table 2). The gp120 genes
isolated from the PBMCs from macaque PPc at 4 weeks
also had a total of three consensus amino acid substi-
tutions (Fig. 2, Table 2). However, at 16 weeks, when only
open vpu clones were detected, the gp120 had accumu-
lated 10 consensus substitutions (Fig. 2, Table 2). By 26
weeks postinoculation, the number of amino acid sub-
stitutions in the gp120 had increased to 23. Most of the
substitutions detected at 16 weeks were retained at 26
weeks. Of the 10 substitutions detected at 16 weeks, 7
(70%) were also detected in gp120 clones isolated at 26
weeks. Examination of the gp120 genes isolated from the
PBMCs of macaque PQc revealed that the number of
consensus amino acid changes remained relatively con-
stant (three or four changes) at 4, 16, and 28 weeks
postinoculation (Fig. 3, Table 2). However, at those time
periods when only open vpu clones were isolated (39, 57,
and 105 weeks), the number of consensus changes in
the gp120 increased to 11 substitutions at week 39 and
further increased to 34 substitutions by week 105 (Fig. 3,
Table 2). As with macaque PPc, most of the consensus
changes at earlier periods of infection were retained at
necropsy (105 weeks). Of the 11 substitutions found at
week 39, 9 (82%) were also detected at 105 weeks.
Similarly, of the 23 substitutions detected at 57 weeks, 19
(83%) were detected at 105 weeks. Taken together, these
data indicate that the increased number of consensus
changes in Nef and gp120 isolated from macaques PPc
and PQc correlated well with the reversion of vpu to an
open reading frame.
Macaques PPc and PQc selected different consensus
changes in the gp120 and Nef during the course of
infection
We determined whether the consensus amino acid
substitutions in the Nef and gp120 clones isolated from
PPc and PQc were similar during the course of their
infections. For macaques PPc and PQc, 5 and 11 con-
sensus amino acid substitutions, respectively, were de-
tected in Nef at necropsy (Table 1). Of the five substitu-
tions in the Nef of PPc, 2 were detected in the nef clones
isolated at necropsy from macaque PQc (Table 1).
The sequence changes in the gp120 clones isolated
from macaques PPc and PQc were also compared with
each other at the first time points during which only open
vpu clones were found (16 weeks for macaque PPc; 39
weeks for macaque PQc) and at necropsy. As shown in
Table 2, macaques PPc and PQc had 10 and 11 consen-
sus amino acid substitutions, respectively. Of the 10
consensus changes found in macaque PPc at 16 weeks,
2 were found in the gp120 genes isolated from macaque
PQc at 39 weeks (Table 1). We also compared the con-
sensus amino acid substitutions found in the gp120
genes isolated at necropsy. At necropsy, macaques PPc
and PQc had 23 and 34 consensus amino acid substitu-
tions, respectively (Table 2). Of the 23 changes found in
the gp120 clones from macaque PPc at 26 weeks, 9 were
also found in the gp120 clones isolated from the PBMCs
from macaque PQc at both 57 and 105 weeks. Taken
together, these data indicate that the majority of the
amino acid substitutions that occurred in the Nef and
gp120 were specific for the macaque from which they
were isolated.
SHIVKU-1 was derived from macaque PPc
We previously analyzed SHIVKU-1 for consensus amino
acid substitutions in several viral genes and found that
the Nef and gp120 of SHIVKU-1 had 5 and 10 predicted
amino acid substitutions, respectively (Stephens et al.,
1997a). Because SHIVKU-1 was derived by inoculation of
macaque PNb with cells obtained from macaques PPc
and PQc at week 16, we compared the nef and gp120
sequences at 16 weeks with the consensus amino acid
sequences derived from SHIVKU-1. At 16 weeks, macaque
PPc had four amino acid substitutions (N72D, Y133F,
I114M, and E155K) in common with SHIVKU-1, whereas
macaque PQc had no common substitutions. Similarly,
the gp120 sequences isolated from PBMCs of macaque
PPc at 16 weeks had six amino acid substitutions
(S192K/T, T202S, R304I, I320M, N460K, and S461G) in
common with SHIVKU-1, whereas macaque PQc only had
two amino acid substitutions (S192K and R304I) in com-
mon with SHIVKU-1. Both of the substitutions found in the
gp120s isolated from the PBMCs of macaque PQc were
also found in the PRc/PLc bone marrow used to inocu-
late these two macaques and thus were not PQc spe-
cific. Not surprisingly, alignment of nef and gp120 se-
FIG. 3. Correlation among the level of CD41 T cells (), status of the
vpu gene (closed, 2; open, 1), and the number of predicted consensus
amino acid substitutions in the gp120 (f) and nef (r) genes isolated
from macaque PQc.
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TABLE 2
Consensus Amino Acid Substitutions in gp120 during the Course of Infection of Macaques PPc and PQc
PLc/PRc BMa PPc PBMCsa PQc PBMCsa
(3)c 4b (3) 16 (10) 26 (23) 4, 16 (3) 28 (3) 39 (11) 57 (23) 105 (34)
T51I
D62H
V65A V65A V65A V65A
H105N H105N
I108V
I109S I109S
Q114E
C126S
K130N K130N K130N
S142R
G145E G145E
M147I
I148M
I161V I161V I161V
I165T I165T I165T
R166S R166S R166S
K168E
F175L F175L
P183Q
D185G
T188A T188A T188A
S192K S192K S192K/T S192T S192K S192K S192E S192E S192E
T194I T194I T194I
V200S
T202S T202S
K207R
A219T
N230D
T232M
N262S
R273S
T278K
D279N D279N
A281T A281V
S291F S291F
V292I
T297A
N300S N300G
R304I R304I R304I R304I R304I R304I R304I R304I R304I
Q310H Q310H Q310H
A316T A316T A316N
I130M I320M I320M I320M
N325D
Q328R
K337R
K362N K362N
T373M
S375M
T408I
E409G
S411R S411R S441K
T413I
I423F I423F
K429R
N460K N460K N460K
S461G S461G S461D S461V
I467V
a DNA was extracted from bone marrow (BM) or peripheral blood mononuclear cells (PBMCs), and the gp120 gene was amplified using appropriate
oligonucleotide primers.
b Weeks postinoculations that samples were collected.
c Number of consensus amino acid substitutions obtained from analysis of five clones from each time period.
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quences from macaques PPc and PQc with the consen-
sus sequences from SHIVKU-1 indicated that SHIVKU-1
was derived from macaque PPc (data not shown).
DISCUSSION
We report here on the chronology of changes in the
vpu, env, and nef genes from the first two macaques that
developed AIDS during the generation of a pathogenic
strain of SHIV-4. Our rationale for analyzing these three
genes was based on the consensus sequence changes
that occurred in pathogenic SHIVKU-1, isolated from the
cerebrospinal fluid of a macaque during the fourth pas-
sage of SHIV-4 in macaques. First, the gp120, and espe-
cially the variable domains (V1–V5), contained the most
amino acid substitutions, with 9 of the 10 consensus
changes occurring in the variable domains (Stephens et
al., 1997b). Amino acid substitutions in the gp120 have
been associated with conversion of lymphocyte-tropic
SHIV-4 virus to a dual-tropic virus and different corecep-
tor use (E. B. Stephens, unpublished data). Second, we
and others have shown that the Nef of SIVmac239 and
HIV-1 can undergo extensive variation, sometimes at a
higher level than that observed in gp120, after inocula-
tion into rhesus macaques (Shuggars et al., 1993; Shu et
al., 1996). Although SHIV-4 was constructed with the tat,
rev, vpu, and env genes of HIV-1 (strain HXB2) in a
genetic background of pathogenic SIVmac239, the vpu
gene did not code for a Vpu protein because the first
codon of the gene was ACG instead of the usual ATG.
Immunoprecipitation studies using antiserum directed
against Vpu did not immunoprecipitate Vpu from cells
infected with SHIV-4. In our characterization of SHIVKU-1,
we showed that the ACG codon of vpu had in fact
reverted to an ATG codon and Vpu could be immunopre-
cipitated from cultures inoculated with SHIVKU-1 (Ste-
phens et al., 1997b).
In this report, we determined whether reversion of vpu
to an open reading frame was associated with a partic-
ular stage of disease in these animals. Previous studies
from our laboratory indicate that the first two passages of
this virus in macaques (the first in rhesus macaques and
the second in pig-tailed macaques) did not result in
significant CD41 T cell loss or disease (Joag et al.,
1996a; Stephens et al., 1996). This lack of pathogenicity
was associated with minimal changes in env, particularly
the V3 domain (Stephens et al., 1997a). However, the
third passage of this virus (second in pig-tailed ma-
caques) in PPc and PPc resulted in a biphasic loss of
CD41 T cells, in AIDS, and in death at 26 and 105 weeks,
respectively. Our data indicate an association between
the beginning of the second (major) phase of CD41 T cell
loss in both macaques and reversion of the ACG codon
to ATG, resulting in the expression of a Vpu protein.
Furthermore, our results indicate that the reversion of
vpu to an open reading frame was associated with an
increase in the number of consensus amino acid
changes in gp120. While it was not possible to ascertain
whether changes in vpu preceded those of gp120, or vice
versa, the available data suggest that changes in both of
these proteins resulted in virus variants that replicated
with increased efficiency in macaque CD41 T cells and
contributed to the second phase of CD41 T cell loss.
While the reversion of vpu to an open reading frame
coincided with an increased number of amino acid
changes in gp120, our data from macaque PQc suggest
that the emergence of Nef variants probably did not
occur until after these two events. This was evident from
an analysis of nef sequences isolated from PBMCs at 28
weeks postinfection, where no consensus changes were
noted in the predicted Nef, whereas 50% of the vpu
clones had reverted to an open reading frame, and 50%
of the gp120 clones had started to acquire additional
amino acid substitutions.
Was an open vpu required for this SHIV (i.e., variants of
SHIV-4) to cause severe CD41 T cell loss and AIDS in
macaques PPc and PQc? Vpu is a membrane-bound
protein that is found only in HIV-1 and SIVcpz (Huet et al.,
1990). Several important biological activities have been
attributed to Vpu, including the ability to induce CD4
degradation in the endoplasmic reticulum (Willey et al.,
1992a,b; Bour et al., 1995), regulate transport of viral
gp160 (Vincent and Jabbar, 1995), and facilitate the re-
lease of virions from infected cells (Strebel et al., 1989;
Klimkait et al., 1990; Schubert and Strebel, 1994; Schu-
bert et al., 1996). However, whether HIV-1, lacking a open
vpu gene, can still cause disease in humans is presently
unknown. Previous studies in which site-directed mu-
tagenesis was used to correct the first codon of vpu of
SHIV-4 (i.e., to an ATG) did not result in virus that was
pathogenic for rhesus macaques (Li et al., 1995). These
results suggest that factors other than the absence of
Vpu contribute to the lack of pathogenicity of SHIV-4.
Previous characterization of SHIVKU-1 indicated that
changes occurred in the LTR, as well as amino acid
substitutions in several viral proteins, including Vpr, Tat,
Rev, Vpu, Env, and Nef. Thus, it is probable that the
virulence associated with variants of SHIV-4 is polygenic
in nature, requiring changes in several genes for this
SHIV to become pathogenic in macaques. However, this
is the first study that suggests that the vpu gene product
of HIV-1 may be essential for the pathogenicity of this
primate lentivirus. The exact role of Vpu in CD41 T cell
loss and pathogenicity will be elucidated through analy-
sis of pathogenic molecular clones of SHIV in which the
vpu gene has been deleted, altered, or both.
MATERIALS AND METHODS
Cells and viruses
The C8166 cell line was used as the indicator cells to
measure infectivity and cytopathicity of the viruses used
280 McCORMICK-DAVIS ET AL.
in this study. C8166 cells were maintained in RPMI 1640,
supplemented with 10 mM HEPES buffer, pH 7.3, 2 mM
glutamine, 50 mg/ml gentamicin, and 10% fetal bovine
serum (R10FBS). The avirulent SHIV-4 used for passage
in rhesus and pig-tailed macaques was constructed by Li
et al. (1992). This virus was constructed with the tat, rev,
vpu, and env genes of the HXB2 strain of HIV-1 in the
genetic background (LTR, gag, pol, vif, vpx, vpr, and nef)
from virulent SIVmac239.
Passage of SHIV-4 to generate a pathogenic variant
virus
SHIV-4 was initially passaged in rhesus macaques
and then in pig-tailed macaques to yield a pathogenic
variant as previously described (Joag et al., 1996a; Ste-
phens et al., 1996). Relevant to this study, ;1 3 108 bone
marrow cells (BMCs) from rhesus macaque 8A were
inoculated into the bone marrow of two 8-month-old
pigtailed animals, PLc and PRc. Five weeks after inocu-
lation, BMC were collected from PLc and PRc, pooled,
and inoculated into two 1-year-old pig-tailed animals,
PPc and PQc. At 16 weeks after inoculation, BMCs from
these two animals were pooled and inoculated into the
bone marrow of macaques PNb and PFb. Macaque PPc,
which showed a biphasic loss in its circulating CD41 T
cells with the second loss beginning at 16 weeks after
inoculation, died from AIDS at 26 weeks after inoculation.
Macaque PQc also demonstrated a biphasic loss of
circulating CD41 T cells. The second wave of CD41 T
cell loss began at ;39 weeks after inoculation and
continued until the animal was euthanized at 105 weeks
postinoculation. SHIVKU-1 was derived by inoculation of
BMCs obtained from macaques PPc and PQc at 16
weeks into macaque PNb and isolation of virus from the
cerebrospinal fluid at 8 weeks postinoculation (Joag et
al., 1996a).
Processing of blood and tissue samples
Heparinized blood was centrifuged to separate the
plasma from the buffy coat. The cells were centrifuged
through Ficoll–Hypaque density gradients to isolate
PBMCs.
For enumeration of the CD41 T cells, isolated PB-
MCs were incubated with a monoclonal antibody to
CD4 (SIM.4; National Institutes of Health AIDS Re-
search AIDS and Reagents Repository) or CD8 (Dako-
T8; DAKO). Cells were washed and stained with an
FITC-conjugated goat anti-mouse IgG (DAKO), fixed in
1% buffered Formalin, and analyzed on an EPICS flu-
orescence-activated cell sorter.
For enumeration of the number of cells in the PBMCs that
are producing infectious virus, infectious centers assays
(ICAs) were performed on serial 10-fold dilutions of isolated
PBMCs from 105 to 102 cells (Joan et al., 1994). Cells were
inoculated into 24-well plates along with 1 ml of freshly
prepared 105 C8166 cells, and cultures were maintained in
sRPMI containing 10% fetal bovine serum, as previously
described (Joag et al., 1994; Zhu et al., 1995).
PCR amplification of SHIV genes
For the studies reported here, total cellular DNA was
extracted from 5 3 106 PBMCs using standard procedures.
For amplification of the vpu, we used oligonucleotide prim-
ers 59-CCTAGACTAGAGCCCTGGAAGCATCC-39 (sense)
and 59-GTACCTCTGTATCATATGCTTTAGCAT-39 (antisense),
which are complementary to nucleotides 5845–5870 and
6393–6420 of the HIV-1 (HXB2) genome (Wong-Staal et al.,
1985), respectively. One microgram of genomic DNA was
used in the polymerase chain reaction (PCR) (Saiki et al.,
1985, 1988) containing 1.4 mM MgSO4, 200 mM concentra-
tion of each of the four deoxynucleotide triphosphates, 100
pM concentration of each oligonucleotide primer, and a
mixture of Taq and Pyrococcus species GB-D polymerases
(Elongase; GIBCO BRL). The template was denatured at
94°C for 2 min, and PCR amplification performed with an
automated DNA Thermal Cycler (Perkin–Elmer Cetus) for
35 cycles using the following profile: denaturation at 94°C
for 30 s, annealing at 65°C for 1 min, and primer extension
at 68°C for 5 min. Amplification was completed by incuba-
tion for 10 min at 68°C. For the second round of amplifica-
tion, we used oligonucleotide primers 59-TTAGGCATCTC-
CTATGGCAGGAAGAAG-39 (sense) and 59-CACAAAATAG-
AGTGGTGGTTGCTTCCT-39 (antisense), which are comple-
mentary to nucleotides 5956–5984 and 6386–6413 of the
HIV-1 (HXB2) genome (Wong-Staal et al., 1985), respectively.
The conditions for amplification were identical to those
described above.
For amplification of the gp120 region of env, we used
oligonucleotides 59-GACTAATAGAAAGAGCAGAAGACA-
GTGGCA-39 (sense) and 59-AGTGCTTCCTGCTGCTCCC-
AAGAACCC-39 (antisense), which are complementary to
nucleotides 6194–6223 and 7784–7810 of the HIV-1
(HXB2) genome (Wong-Staal et al., 1985), respectively.
For the second round of PCR, we used oligonucleotide
primers 59-ATGAGAGTGAAGGAGAAATATCAGCAC-39
(sense) and 59-GAACAAAGCTCCTATTCCCACTGCTCT-39
(antisense), which are complementary to nucleotides
6224–6250 and 7754–7780 of the HIV-1 (HXB2) genome
(Wong-Staal et al., 1985), respectively. The conditions for
amplification were the same as those described above.
For amplification of nef, the following oligonucleotide
primers were used. For the first round of PCR, oligonu-
cleotide primers 59-CCACATACCTAGAAGAATAAGACA-
GGG-39 (sense) and 59-ACATCCCCTTGTGGAAAGTCCC-
TGCTGTTT-39 (antisense) were used. These two primers
are complementary to nucleotides 8746–8772 of the
HIV-1 (HXB2) genome (Wong-Steal et al., 1985) and 9868–
9898 of the SIVmac239 genome (Rigier and Desrosiers,
1990), respectively. For the second round, oligonucleo-
tide primers 59-ATGGGTGGAGCTATTTCCATGAGGCGG-
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TCC-39 (sense) and 59-TCAGCGAGTTTCCTTCTTGTCAG-
CCAT-39 (antisense) were used. These two primers are
complementary to nucleotides 9077–9106 and 9842–
9868 of the SIVmac239 genome (Regier and Desrosiers,
1990), respectively.
Molecular cloning of amplified DNA products and
sequence analyses
The amplified products from three separate reactions
were separated by electrophoresis in a 1% agarose gel,
isolated, and then molecularly cloned into the pGEM-T
vector according to the manufacturer’s instructions. Plas-
mids containing vpu, gp120, or nef sequences from three
separate PCR amplifications were sequenced by primer-
directed dideoxy sequencing using Sequenase enzyme
(U.S. Biochemicals, Cleveland, Ohio) and 35S-dATP. Se-
quences were compared with HIV-1 (HXB2) or SIVmac239
using the PCGENE sequence analysis software pro-
grams.
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